{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:31:54Z","timestamp":1786545114970,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1038\/ajg.2011.219","type":"journal-article","created":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T08:04:30Z","timestamp":1311062670000},"page":"1777-1786","source":"Crossref","is-referenced-by-count":59,"title":["A Randomized Controlled Trial of an Integrated Care Intervention to Increase Eligibility for Chronic Hepatitis C Treatment"],"prefix":"10.14309","volume":"106","author":[{"given":"Donna M","family":"Evon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Kixmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Galanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Golin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W","family":"Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210210","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s10620-006-9669-0","article-title":"High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities.","volume":"52","author":"Evon","year":"2007","journal-title":"Dig Dis Sci"},{"key":"R2-10-20210210","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7326\/0003-4819-136-4-200202190-00008","article-title":"Surprisingly small effect of antiviral treatment in patients with hepatitis C.","volume":"136","author":"Falck-Ytter","year":"2002","journal-title":"Ann Intern Med"},{"key":"R3-10-20210210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004836-200203000-00015","article-title":"A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection.","volume":"34","author":"Muir","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R4-10-20210210","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1572-0241.2005.41860.x","article-title":"Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.","volume":"100","author":"Bini","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R5-10-20210210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00003495-200666020-00003","article-title":"Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management.","volume":"66","author":"Loftis","year":"2006","journal-title":"Drugs"},{"key":"R6-10-20210210","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1370\/afm.62","article-title":"Management of patients with hepatitis C in a community population: diagnosis, discussions, and decisions to treat.","volume":"2","author":"Rocca","year":"2004","journal-title":"Ann Fam Med"},{"key":"R7-10-20210210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJM200107193450311","article-title":"Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?","volume":"345","author":"Edlin","year":"2001","journal-title":"N Engl J Med"},{"key":"R8-10-20210210","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1365-2036.2006.03107.x","article-title":"Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C.","volume":"24","author":"Castera","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-10-20210210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jhep.2003.50031","article-title":"Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.","volume":"37","author":"Schaefer","year":"2003","journal-title":"Hepatology"},{"key":"R10-10-20210210","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1360-0443.2004.00821.x","article-title":"Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?","volume":"99","author":"Schaefer","year":"2004","journal-title":"Addiction"},{"key":"R11-10-20210210","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/hep.21791","article-title":"Hepatitis C treatment in difficult-to-treat psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.","volume":"46","author":"Schaefer","year":"2007","journal-title":"Hepatology"},{"key":"R12-10-20210210","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/j.1572-0241.2008.01877.x","article-title":"Management of chronic hepatitis C in veterans: the potential of integrated care models.","volume":"103","author":"Ho","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 5","key":"R13-10-20210210","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1086\/427450","article-title":"Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.","volume":"40","author":"Litwin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R14-10-20210210","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jurban\/jth153","article-title":"Co-occurring hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.","volume":"81","author":"Sylvestre","year":"2004","journal-title":"J Urban Health"},{"issue":"Suppl 3","key":"R15-10-20210210","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1097\/01.aids.0000192089.54130.b6","article-title":"Hepatitis C virus treatment decision-making in the context of HIV co-infection: the role of medical, behavioral and mental health factors in assessing treatment readiness.","volume":"19","author":"Wagner","year":"2005","journal-title":"AIDS"},{"key":"R16-10-20210210","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1176\/ps.2006.57.4.570","article-title":"Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness.","volume":"57","author":"Rifai","year":"2006","journal-title":"Psychiatr Serv"},{"key":"R18-10-20210210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1155\/2008\/949582","article-title":"Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic.","volume":"22","author":"McLaren","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"R19-10-20210210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2105\/AJPH.91.1.31","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.","volume":"91","author":"Rosenberg","year":"2001","journal-title":"Am J Public Health"},{"key":"R20-10-20210210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0010-440X(03)00094-4","article-title":"Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders.","volume":"44","author":"Klinkenberg","year":"2003","journal-title":"Compr Psychiatry"},{"key":"R21-10-20210210","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1053\/jhep.2000.7880","article-title":"Hepatitis C, interferon alfa, and depression.","volume":"31","author":"Zdilar","year":"2000","journal-title":"Hepatology"},{"key":"R22-10-20210210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1300\/J069v20n01_03","article-title":"Hepatitis C in methadone maintenance patients: prevalence and public policy implications.","volume":"20","author":"McCarthy","year":"2001","journal-title":"J Addict Dis"},{"key":"R24-10-20210210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.drugpo.2007.01.013","article-title":"Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.","volume":"18","author":"Birkhead","year":"2007","journal-title":"Int J Drug Policy"},{"issue":"Suppl 3","key":"R25-10-20210210","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1097\/01.aids.0000192092.38883.22","article-title":"Supported medical care: a multi-faceted approach to helping HIVhepatitis C virus co-infected adults with serious mental illness.","volume":"19","author":"Goldberg","year":"2005","journal-title":"AIDS"},{"key":"R26-10-20210210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MEG.0b013e32832a8c4c","article-title":"Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support.","volume":"22","author":"Grebely","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R27-10-20210210","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1080\/09540120701335196","article-title":"A model of integrated primary care for HIV-positive patients with underlying substance use and mental illness.","volume":"19","author":"Zaller","year":"2007","journal-title":"AIDS Care"},{"issue":"Suppl 3","key":"R28-10-20210210","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1097\/01.aids.0000192094.84624.c2","article-title":"Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches.","volume":"19","author":"Willenbring","year":"2005","journal-title":"AIDS"},{"key":"R29-10-20210210","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/j.1572-0241.2006.00731.x","article-title":"Integrated psychiatricmedical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes.","volume":"101","author":"Knott","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R30-10-20210210","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.drugpo.2007.01.009","article-title":"Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.","volume":"18","author":"Grebely","year":"2007","journal-title":"Int J Drug Policy"},{"key":"R31-10-20210210","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1097\/MCG.0b013e3181d88af5","article-title":"A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin.","volume":"44","author":"Neri","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R33-10-20210210","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1037\/h0090198","article-title":"Stages of change in psychotherapy: measurement and sample profiles.","volume":"20","author":"McConnaughy","year":"1983","journal-title":"Psychotherapy: Theory, Research and Practice"},{"key":"R36-10-20210210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jsat.2007.01.011","article-title":"A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders.","volume":"34","author":"Drake","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"R37-10-20210210","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/QAI.0b013e3181684c51","article-title":"Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II.","volume":"47","author":"Craw","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R38-10-20210210","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/09540120701294302","article-title":"Case management community care for people living with HIVAIDS (PLHAs).","volume":"19","author":"Husbands","year":"2007","journal-title":"AIDS Care"},{"key":"R42-10-20210210","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II.","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"R44-10-20210210","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"key":"R45-10-20210210","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/jac\/dkq157","article-title":"Antiviral therapy for hepatitis C: why are so few patients being treated?","volume":"65","author":"Volk","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R46-10-20210210","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.23220","article-title":"Public health impact of antiviral therapy for hepatitis C in the United States.","volume":"50","author":"Volk","year":"2009","journal-title":"Hepatology"},{"key":"R47-10-20210210","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1525-1497.2005.0161.x","article-title":"Barriers to the treatment of hepatitis C. Patient, provider, and system factors.","volume":"20","author":"Morrill","year":"2005","journal-title":"J Gen Intern Med"},{"key":"R48-10-20210210","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1365-2036.2010.04460.x","article-title":"Barriers to accessing care in patients with chronic hepatitis C: the impact of depression.","volume":"32","author":"Evon","year":"2010","journal-title":"Aliment Pharmacol Therap"},{"issue":"Suppl 12","key":"R49-10-20210210","first-page":"S327","article-title":"Making it happen: managed care considerations in vanquishing hepatitis C.","volume":"13","author":"McHutchison","year":"2007","journal-title":"Am J Manag Care"},{"issue":"Suppl 1","key":"R50-10-20210210","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1080\/09540120412331315295","article-title":"Literature on integrated HIV care: a review.","volume":"16","author":"Soto","year":"2004","journal-title":"AIDS Care"},{"key":"R52-10-20210210","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1572-0241.2002.05800.x","article-title":"Spectrum of disease in U.S. veteran patients with hepatitis C.","volume":"97","author":"Nguyen","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R53-10-20210210","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11938-006-0007-6","article-title":"Psychiatric management of the hepatitis C patient.","volume":"9","author":"Rifai","year":"2006","journal-title":"Curr Treat Opt Gastroenterol"},{"key":"R54-10-20210210","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1023\/A:1016369114780","article-title":"Do Internet-based support interventions change perceptions of social support? an experimental trial of approaches for supporting diabetes self-management.","volume":"30","author":"Barrera","year":"2002","journal-title":"Am J Comm Psychol"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2011219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2011219","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2011219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201110000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:36:34Z","timestamp":1786541794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201110000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2011.219","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}